Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.
Olgram has raised €1.5M across 1 funding round, most recently a Seed round in Apr 2021. Based in Bréhan-Loudéac, France; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-04-05 | Seed | €1.5M |
| — |
| View deal → |
